课题基金 / 基金详情

The development for novel positron-labeled radiopharmaceuticals and their application to measurement of the cerebral functions

The development for novel positron-labeled radiopharmaceuticals and their application to measurement of the cerebral functions
新型正电子标记放射性药物的研制及其在脑功能测量中的应用
批准号:
11694234
负责人:
YANAI Kazuhiko
金额:
$12.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001

项目摘要

项目成果

YANAI Kazuhiko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Positron emission tomography (PET) is a unique method to examine brain chemistry non-invasively in humans. Using PET techniques, specific neurochemical systems, such as dopaminergic and histaminergic neuronal systems, were measured in the living human brain. Specific ^<11>C- or ^<18>F-labelled radiotracers for selective labeling of several receptors were newly synthesized by new synthetic methods. We also developed several new methods of imaging in the human brain using 3-demensional PET system. Our developed PET methods for human neuropharmacology are as follows : Non-invasive measurement of receptor binding parameters ; cerebral activation study with H_2^<15>O and 3D-PET ; ^<11>C-ligand activation study to measure neurotransmitter release. As for pharmacological applications, we used PET techniques for evaluating sedative properties of antihistamines. Antihistamines are the efficacious drugs to be used for the symptomatic relief of allergic diseases. The safety issue of antihistamine … More s is of central importance because of their widespread use in current medical practice. PET was used to better understand the pharmacological effects of antihistamines on the central nervous system. The H1 receptor occupancy was examined in young male volunteers with [^<11>C]-doxepin (a potent H1 antagonist) after the oral or intravenous administration of antihistamines. In other studies, the cognitive performance was also measured tachistoscopically before and after taking antihistamines. The H1 receptor occupancy in the human frontal cortex caused by antihistamines is significantly correlated with the reported values of incidence of sleepiness in clinical trials, and the occupancy is well proportional to the impaired cognitive performance. To understand the brain mechanism of antihistamine-induced "sleepiness and impaired cognition", the regional cerebral blood flow (rCBF) during the task was measured using 3D-PET and H_2^<15>O before and after administration of d-chlorpheniramine. After its administration, the rCBF was significantly decreased on the bilateral middle temporal gyrus, midbrain and anterior cingulate. These findings suggest that H1 receptor blockade would be affected on the activity of the attention and cognitive system in the brain. Less
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
N.Okamura, K.Yanai, M.Higuchi, J.Sakai, R.Iwata, T.Ido, H.Sasaki, T.Watanabe, M.Itoh.: "Functional neuroimaging of cognition impaired by a classical antihistamine, d-chlorpheniramine."Br.J.Pharmacol.. 129. 115-123 (2000)
N.Okamura、K.Yanai、M.Higuchi、J.Sakai、R.Iwata、T.Ido、H.Sasaki、T.Watanabe、M.Itoh.:“经典抗组胺药损害认知的功能神经影像学,d-
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M.Endou, K.yanai, et al.: "Food-deprived activity stress decreased the activity of the histaminergic neurou system in rats"Brain Research. 891. 32-41 (2001)
M.Endou、K.yanai 等人:“食物剥夺的活动压力降低了大鼠组胺能神经系统的活动”大脑研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
R. Iwata, C. Pascali, A. Bongi, G. Horvath, Z. Kovacs, K. Yanai, T. Ido: "A new, convenient method for the preparation of 4-[^<18>F]fluorobenzyl halides"Appl. Radiat. Isot.. 52. 87-92 (2000)
R. Iwata、C. Pascali、A. Bongi、G. Horvath、Z. Kovacs、K. Yanai、T. Ido:“一种制备 4-[^ 18 F]氟苄基卤化物的新且便捷的方法”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M. Izumizaki, M. Iwase, H. Kimura, K. Yanai, T. Watanabe, T. Watanabe, I. Homma: "Lack of temperature-induced polypnea in histamine H1 receptor-deficient mice"Neurosci. Lett.. 284(3). 139-142 (2000)
M. Izumizaki、M. Iwase、H. Kimura、K. Yanai、T. Watanabe、T. Watanabe、I. Homma:“组胺 H1 受体缺陷小鼠中缺乏温度诱导的呼吸暂停”Neurosci。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
39
    Molecular mechanism of brain histamine clearance
    • 批准号:
      26670117
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2014
    • 负责人:
      YANAI Kazuhiko
    • 依托单位:
    Integrated research of histamine system from molecular to wholeanimals and humans using leading-edge technologies
    • 批准号:
      21390171
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.48万
    • 财政年份:
      2009
    • 负责人:
      YANAI Kazuhiko
    • 依托单位:
    Molecular Neuropharmacology on histamine system : From basic to clinical investigation on unsolved issues
    • 批准号:
      19390061
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.06万
    • 财政年份:
      2007
    • 负责人:
      YANAI Kazuhiko
    • 依托单位:
    A study of the histamine neuron system : Its correlation to newly-discovered hypothalamic peptides.
    • 批准号:
      14370027
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.9万
    • 财政年份:
      2002
    • 负责人:
      YANAI Kazuhiko
    • 依托单位:
    国内基金
    海外基金
    间位芳纶(PMIA)短切纤维-涤纶(PET)浆粕复合纸的制备设备研发
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      许红伍
    • 依托单位:
    基于18F-FAPI-04 PET/CT与增强CT的Suidan评分在卵巢癌减瘤术前评估中的价值比较研究
    • 批准号:
      2026JJ81876
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      戴嘉舜
    • 依托单位:
    基于高灵敏度PET/CT的碳离子放疗剂量验证与疗效预测研究
    PET分子影像评估肾癌碳酸酐酶9表达异质性及其对靶免联合治疗响应的预测作用与机制研究
    • 批准号:
      JCZRLH202600197
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位: